U.S. Congressmen Call On China To Bring To Justice Those Who Deliberately Adulterated Heparin

BEIJING - Although the case of nearly 150 patients across American hospitals who died after being given heparin that was deliberately adulterated in China two years ago had seemed to fade from front pages and some regulatory radar screens, two U.S. congressmen have been waging a vigil-like campaign for U.S. FDA leaders to press Chinese counterparts to help bring those responsible to justice